ArticleActa dermato-venereologica2026

Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).

Elena Pezzolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.